Search

everythinglearnresearchcommunity

for

Search:↓

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

New and repurposed treatments are improving outcomes in dermatology.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

Reduced EGFR signaling delays hair cycle and reduces fat growth, but hair development remains normal.

Phenol is effective for skin treatments but poses serious health risks and must be used cautiously by trained doctors.

Sorafenib may cause hair loss in a way similar to alopecia areata.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Folate may reduce methotrexate side effects in psoriasis patients, but its impact on effectiveness is unclear.

Cuscuta reflexa extracts helped regrow hair in rats with drug-induced hair loss.

Inherited ichthyoses cause widespread skin scaling and thickening due to gene mutations.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Treating hair loss requires a comprehensive approach that addresses both physical and emotional aspects, with a focus on diagnosis, patient education, and good communication.

Surgery can help treat vitiligo when other treatments don't work.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Pubertal acne is linked to hormonal changes, affects quality of life, and is treated similarly to adult acne.

Common cosmetic dermatology techniques improve skin damaged by the sun and aging.

Many dermatologists in Saudi Arabia recommend vitamins and minerals for hair loss, often based on personal experience rather than strong evidence.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.

A man developed skin issues from cancer medication, which improved with specific treatments.

A woman's health issues were caused by arsenic poisoning from kelp supplements.

Endocrine therapies for cancer significantly increase the risk of hair loss.

An 81-year-old man's white hair began to regain its original color while he was treated with lenalidomide, suggesting that graying hair might be reversible.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

Oral cyclosporine combined with Pantogar® effectively treats twenty-nail dystrophy.